3-20040662-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003884.5(KAT2B):c.185G>A(p.Gly62Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,526,918 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0010 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 3 hom. )
Consequence
KAT2B
NM_003884.5 missense
NM_003884.5 missense
Scores
1
2
16
Clinical Significance
Conservation
PhyloP100: 2.14
Genes affected
KAT2B (HGNC:8638): (lysine acetyltransferase 2B) CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. It has histone acetyl transferase activity with core histones and nucleosome core particles, indicating that this protein plays a direct role in transcriptional regulation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0066883564).
BP6
Variant 3-20040662-G-A is Benign according to our data. Variant chr3-20040662-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3035151.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 154 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAT2B | NM_003884.5 | c.185G>A | p.Gly62Asp | missense_variant | 1/18 | ENST00000263754.5 | NP_003875.3 | |
KAT2B | XM_005265528.5 | c.185G>A | p.Gly62Asp | missense_variant | 1/17 | XP_005265585.1 | ||
KAT2B | XM_047449147.1 | c.-311G>A | 5_prime_UTR_variant | 1/20 | XP_047305103.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KAT2B | ENST00000263754.5 | c.185G>A | p.Gly62Asp | missense_variant | 1/18 | 1 | NM_003884.5 | ENSP00000263754.4 | ||
KAT2B | ENST00000426228.1 | n.-36G>A | upstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.00102 AC: 154AN: 151506Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
154
AN:
151506
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00132 AC: 181AN: 136946Hom.: 1 AF XY: 0.00112 AC XY: 88AN XY: 78782
GnomAD3 exomes
AF:
AC:
181
AN:
136946
Hom.:
AF XY:
AC XY:
88
AN XY:
78782
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00144 AC: 1986AN: 1375304Hom.: 3 Cov.: 32 AF XY: 0.00143 AC XY: 977AN XY: 682402
GnomAD4 exome
AF:
AC:
1986
AN:
1375304
Hom.:
Cov.:
32
AF XY:
AC XY:
977
AN XY:
682402
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00102 AC: 154AN: 151614Hom.: 1 Cov.: 31 AF XY: 0.000891 AC XY: 66AN XY: 74070
GnomAD4 genome
AF:
AC:
154
AN:
151614
Hom.:
Cov.:
31
AF XY:
AC XY:
66
AN XY:
74070
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
119
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
KAT2B-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 20, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Uncertain
T
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at